Skolsky Steven D

Director at SYNAGEVA BIOPHARMA CORP · on record since Jan 3, 2006
Chief Executive Officer at SYNAGEVA BIOPHARMA CORP · on record since Jan 3, 2006
Director at NVN Liquidation, Inc. · on record since Mar 2, 2021

Insider trading activity of Skolsky Steven D

Transactions on record: 15; since Sep 9, 2004

Open-market buys: 0

Open-market sells: 0

Companies traded: 2; last filing Jun 8, 2023

Figures computed from official regulatory filings — .

Companies where Skolsky Steven D has traded

NVN Liquidation, Inc.7 tx · Jun 8, 2023
SYNAGEVA BIOPHARMA CORP8 tx · Oct 2, 2006

Track record of Skolsky Steven D

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Skolsky Steven D

Co-insiders of Skolsky Steven D

14159 capital (GP), LLCSYNAGEVA BIOPHARMA CORP
14159, L.P.SYNAGEVA BIOPHARMA CORP
667, L.P.SYNAGEVA BIOPHARMA CORP
AKKARAJU SRINIVASSYNAGEVA BIOPHARMA CORP
ALEXION PHARMACEUTICALS INCSYNAGEVA BIOPHARMA CORP
Alrutz Michael ASYNAGEVA BIOPHARMA CORP
Baker Biotech Capital (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Capital II (A) (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Capital II (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Capital III (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Capital II (Z) (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Biotech Fund II (A), L.P.SYNAGEVA BIOPHARMA CORP
Baker Bros. Advisors (GP) LLCSYNAGEVA BIOPHARMA CORP
BAKER BROS. ADVISORS LPSYNAGEVA BIOPHARMA CORP
Baker Bros. Capital (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker Bros. Investments II, L.P.SYNAGEVA BIOPHARMA CORP
Baker Bros. Investments, L.P.SYNAGEVA BIOPHARMA CORP
Baker Brothers Life Sciences LPSYNAGEVA BIOPHARMA CORP
BAKER FELIXSYNAGEVA BIOPHARMA CORP
BAKER JULIANSYNAGEVA BIOPHARMA CORP
Baker / Tisch Capital (GP), LLCSYNAGEVA BIOPHARMA CORP
Baker/Tisch Investments, LPSYNAGEVA BIOPHARMA CORP

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
NVN Liquidation, Inc.Listing unverified	Jun 8, 2023	AwardD (derivative)	103,092	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	Jun 8, 2023	ExerciseD (derivative)	-36,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	Jun 8, 2023	Exercise	36,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	Jun 9, 2022	AwardD (derivative)	36,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	May 28, 2021	AwardD (derivative)	8,923	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	May 6, 2021	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	Mar 2, 2021	AwardD (derivative)	31,970	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Oct 2, 2006	AwardD (derivative)	18,750	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Aug 9, 2006	AwardD (derivative)	18,750	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Apr 3, 2006	AwardD (derivative)	16,618	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jan 3, 2006	AwardD (derivative)	16,618	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Oct 3, 2005	AwardD (derivative)	16,618	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Aug 11, 2005	AwardD (derivative)	16,618	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Sep 9, 2004	AwardD (derivative)	350,000	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Sep 9, 2004	Award	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
NVN Liquidation, Inc.Listing unverified	Jun 8, 2023	AwardD (derivative)	103,092	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	Jun 8, 2023	ExerciseD (derivative)	-36,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	Jun 8, 2023	Exercise	36,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	Jun 9, 2022	AwardD (derivative)	36,101	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	May 28, 2021	AwardD (derivative)	8,923	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	May 6, 2021	AwardD (derivative)	35,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NVN Liquidation, Inc.Listing unverified	Mar 2, 2021	AwardD (derivative)	31,970	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Oct 2, 2006	AwardD (derivative)	18,750	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Aug 9, 2006	AwardD (derivative)	18,750	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Apr 3, 2006	AwardD (derivative)	16,618	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Jan 3, 2006	AwardD (derivative)	16,618	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Oct 3, 2005	AwardD (derivative)	16,618	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Aug 11, 2005	AwardD (derivative)	16,618	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Sep 9, 2004	AwardD (derivative)	350,000	—	n/a (No price was disclosed in the filing)	SEC
SYNAGEVA BIOPHARMA CORPListing unverified	Sep 9, 2004	Award	50,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC